Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jjw14
    Member
    • Apr 2010
    • 39

    #1

    Peak finding with MACS: Questions on # of reads and "strand bias"

    Hi,

    I have ChIP-seq data generated using a methylcytosine antibody and the Illumina GAII. For each sample, I have an input control (IC) and an immunoprecipitated (IP) sample. Bowtie was used to generate alignments.

    MACS will locate peaks, but I have some concerns/questions:

    1. Is there a minimum number of reads that a peak should be composed of? I've seen publications where it looks like peaks have hundreds of reads, and others where a peak only has 30 reads.

    2. In my samples, some peaks are composed mainly of reads on either the +ve or the -ve strand, while other peaks have an equal distribution of both. Is there any strand "ratio" that defines a "true" peak versus an artifact? It would seem impossible to go through and visually verify each peak.

    3. Some people suggest using mfold values between 10 and 30, while others report using 5. The MACS website seems to suggest not going below 10, but is there rule of thumb to determine the optimal mfold value for a specific data set?

    Sorry for so many questions. I just want to make sure the data I report is valid. Thanks in advance,
    jjw

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...